Conclusion
Intravenous Nicorandil could significantly reduce systolic and diastolic
blood pressure in patients without affecting heart rate, and it reduced
in depending on concentrations, suggesting that Intravenous Nicorandil
may be a new intravenous antihypertensive drug in future clinical
application.